ELAN PHARMA INTERNATIONAL LTD.

Related Filers (82)

Other (11)

EFFECT
Tuesday, 9/2/2014
Notice of Effectiveness
CORRESP
Thursday, 8/28/2014
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Wednesday, 8/27/2014
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Wednesday, 8/27/2014
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
EFFECT
Thursday, 6/23/2011
Notice of Effectiveness
F-4/A
Wednesday, 6/22/2011
Registration statement for securities issued by foreign private issuers in certain business combination transactions
F-4
Tuesday, 3/29/2011
Registration statement for securities issued by foreign private issuers in certain business combination transactions
EFFECT
Tuesday, 4/10/2007
Notice of Effectiveness
F-4/A
Thursday, 4/5/2007
Registration statement for securities issued by foreign private issuers in certain business combination transactions
F-4
Wednesday, 2/28/2007
Registration statement for securities issued by foreign private issuers in certain business combination transactions
F-4
Friday, 9/9/2005
Registration statement for securities issued by foreign private issuers in certain business combination transactions
Show More

Ownership (4)

4
Thursday, 2/18/2016
PROTEOSTASIS THERAPEUTICS, INC.: Statement of changes in beneficial ownership of securities
3/A
Thursday, 2/18/2016
PROTEOSTASIS THERAPEUTICS, INC.: Initial statement of beneficial ownership of securities
3
Friday, 8/2/2013
Lipocine Inc.: Initial statement of beneficial ownership of securities
SC 13D/A
Tuesday, 11/2/2004
AMARIN CORP PLC\UK: Major Shareholders
Show More

Prospectus (4)

424B3
Tuesday, 9/2/2014
Prospectus filed pursuant to Rule 424(b)(3)
S-4
Friday, 8/15/2014
Registration of securities issued in business combination transactions
424B3
Tuesday, 4/10/2007
Prospectus filed pursuant to Rule 424(b)(3)
424B3
Wednesday, 9/28/2005
Prospectus filed pursuant to Rule 424(b)(3)
Show More